High-Throughput Screening – Products

Biacore™ 8 series SPR systems

Your discovery — accelerated. With maximized capacity. High quality binding data to meet your toughest challenges in screening, characterization, process optimization, and quality control.

Download this compendium to learn more about developments in high-throughput screening, target-based drug discovery and fragment-based drug discovery.

This app note highlights how a handheld electronic pipette can help researchers save time and increase homogeneous crystal growth.

Discover a system that brings the ease of compound tuning, and the specificity of mass spectrometry, into the throughput realm of plate readers.

Research is like high-stakes poker. The prize? A blockbuster drug. The risk? Billions lost on a dud. Winning comes down to having the best tools to spot the most promising leads.

This app note highlights how reliable kinetics and affinity for high-affinity interactions can be obtained from significantly less data than is commonly used.

Ganymede Bio and Kytopen have announced a partnership to bring the power of cloud-native, structured data to Kytopen’s Flowfect® platforms.

Metrion Biosciences announced it has received notification from the MHRA that the Company is now a member of the UK GLP Compliance Monitoring Programme.

Arrayjet, announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering.

The journey from drug discovery to market launch is a complex and expensive pathway that typically spans several decades. There are many factors involved in identifying and designing a successful candidate at various stages of the development pipeline including screening, design, kinetics, scale-up and many more